SCHEMBL10983166

SCHEMBL10983166

COc1cc(Cl)c(Cl)cc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
ALDH1A1 P00352 5/20 0.50
TDP1 Q9NUW8 3/20 0.50
MAPT P10636 4/20 0.49
KDM4E B2RXH2 2/20 0.49
CYP3A4 P08684 1/20 0.49
ALOX15 P16050 1/20 0.49
PRKDC P78527 1/20 0.49
HSD17B10 Q99714 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.44
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44
TUBB4B P68371 1/20 0.44
TUBB3 Q13509 1/20 0.44
TUBB2A Q13885 1/20 0.44
TUBB8 Q3ZCM7 1/20 0.44
TUBA3E Q6PEY2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL310130 0.90 LMNA (0.54) LMNAALDH1A1TDP1MAPTKDM4E
SCHEMBL8536622 0.90 MERTK (0.51) LMNAALDH1A1TDP1MAPTKDM4E
SCHEMBL31188768 0.90 LMNA (0.54) LMNAALDH1A1TDP1MAPTKDM4E
SCHEMBL30435204 0.90 MERTK (0.51) LMNAALDH1A1TDP1MAPTKDM4E
SCHEMBL11661312 0.90 ALDH1A1 (0.48) LMNAALDH1A1TDP1MAPTKDM4E
SCHEMBL29739541 0.87 ALDH1A1 (0.49) LMNAALDH1A1TDP1MAPTKDM4E
SCHEMBL359390 0.87 ALDH1A1 (0.49) LMNAALDH1A1TDP1MAPTKDM4E
Methyl Alcohol SCHEMBL28097248 0.87 LMNA (0.55) LMNAALDH1A1TDP1MAPTKDM4E
SCHEMBL11416083 0.87 ALDH1A1 (0.46) LMNAALDH1A1TDP1MAPTKDM4E
SCHEMBL3122999 0.87 RAB9A (0.50) LMNAALDH1A1TDP1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170369486-A1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTONIC ACETYLCHOLINE RECEPTORS AXOVANT SCIENCES GMBH (CH) 2017-12-28 US disclosed
US-4532350-A Process for the selective preparation of meta-chloroanilines RHONE-POULENC AGROCHIMIE (FR) 1985-07-30 US disclosed
EP-0045709-B1 PROCESS FOR THE PREPARATION OF META-CHLORINATED ANILINES RHONE-POULENC AGROCHIMIE (FR) 1984-10-03 EP disclosed
EP-0045710-B1 PROCESS FOR THE SELECTIVE PREPARATION OF META-CHLORINATED ANILINES RHONE-POULENC AGROCHIMIE (FR) 1984-07-04 EP disclosed
US-4418213-A HYDRODEHALOGENATION LEWIS ACID AND NOBLE METAL CATALYSTS RHONE-POULENC AGROCHIMIE (FR) 1983-11-29 US disclosed
US-4351959-A Process for preparation of anilines substituted by chlorine in the meta-position RHONE-POULENC AGROCHIMIE (FR) 1982-09-28 US disclosed
US-4340759-A Process for the preparation of anilines substituted by chlorine in the meta-position RHONE-POULENC AGROCHIMIE (FR) 1982-07-20 US disclosed
EP-0015220-B1 PROCESS FOR THE PREPARATION OF META-CHLORO ANILINES RHONE-POULENC AGROCHIMIE (FR) 1982-05-12 EP disclosed
US-4324914-A Process for preparation of anilines substituted by chlorine in the meta-position RHONE-POULENC AGROCHIMIE (FR) 1982-04-13 US disclosed
EP-0045709-A1 Process for the preparation of meta-chlorinated anilines RHONE-POULENC AGROCHIMIE (FR) 1982-02-10 EP disclosed
EP-0045710-A1 Process for the selective preparation of meta-chlorinated anilines RHONE-POULENC AGROCHIMIE (FR) 1982-02-10 EP disclosed
EP-0015219-B1 PROCESS FOR THE PREPARATION OF META-CHLORO ANILINES RHONE-POULENC AGROCHIMIE (FR) 1981-10-28 EP disclosed
EP-0015220-A1 Process for the preparation of meta-chloro anilines RHONE-POULENC AGROCHIMIE (FR) 1980-09-03 EP disclosed
EP-0015219-A1 Process for the preparation of meta-chloro anilines RHONE-POULENC AGROCHIMIE (FR) 1980-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369486-A1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTONIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA6, CHRNA5 LMNA 2908/4885ALDH1A1 2708/4885TDP1 1948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.